Release Date: 17/08/10 15:23 Summary: Appendix 3Y - Change of Directors Interest Notice - Stubbs Price Sensitive: No Download Document 101.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%